A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors and sometimes eliminating them entirely.

Former Brentford boss Thomas Frank says it will be "special" to return to Gtech Community Stadium for the first time since he ...

In 2025, Asbury Park Press journalists produced a steady stream of the kind of work that tells readers we do this for you, to ...

Liverpool have conceded 12 times from set-piece situations this season - it's a worrying trend that needs to change, writes ...

The elite Bundeswehr unit allegedly allowed a culture of misconduct to persist for years, such as antisemitism, sexual ...